抑肝散对抽动障碍儿童青少年精神行为影响的随机双盲对照初步研究
本研究为随机双盲对照初步试验,38例抽动障碍儿童青少年分为抑肝散组与安慰剂组各19例,疗程4周。主要结局为耶鲁抽动严重程度量表(YGTSS)总分及分量表变化。结果显示仅在第1周时抑肝散组发声抽动强度评分低于安慰剂组(p=.008),其余时间点无显著差异,4周服药依从性可接受。
要点
- 抑肝散仅在第1周降低发声抽动强度评分,其余时间点与安慰剂无差异。
- 4周口服抑肝散在儿童青少年抽动障碍中依从性可接受。
- 本研究为初步试验,安慰剂与剂量选择及长期观察需进一步研究。
核心结论
- 口服抑肝散1周仅降低发声抽动强度评分,提示短期可能减轻强度,4周依从性可接受。
- 因属初步研究,合适安慰剂与剂量选择及长期观察是未来研究关键。
研究设计与样本
- 随机双盲对照初步研究,共38例抽动障碍儿童青少年,对照组19例接受抑肝散安慰剂(90%淀粉与10%抑肝散,2.5g每日三次),治疗组19例接受抑肝散,疗程4周。
主要发现
- 发声抽动强度评分在服药前及第2、3、4周两组间无显著差异(2.94±1.14 vs 2.79±1.08,p=.686;2.29±1.21 vs 1.95±1.08,p=.370;2.41±1.18 vs 2.05±1.51,p=.435;2.29±1.26 vs 1.84±1.42,p=.323)。
- 第1周口服抑肝散后治疗组发声抽动强度评分为1.89±1.10,低于对照组的3.06±1.39(p=.008)。
关键数值与推荐
- 主要结局为耶鲁抽动严重程度量表(YGTSS)总分及分量表评分变化。
临床怎么用
- 可考虑抑肝散短期用于减轻抽动障碍儿童青少年发声抽动强度,但需注意证据仅为初步且仅第1周显示差异。
局限性
- 本研究为初步研究,样本量有限,安慰剂选择与剂量及长期疗效尚未确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Gilles de la Tourette's Syndrome (TS) is a childhood-onset disease with clinical features of motor and phonic tics. Yi-Gan-san (YGS) is a traditional Chinese medicine formula that can reduce aggressiveness and agitation and inhibit dopamine function. This study investigated the effects of YGS on the psychiatric behavior of children and adolescents with TS. METHODS: A double-blind, randomized, controlled preliminary study was conducted. A total of 38 patients with TS were assigned to the control group (CG, 19 patients) who received the oral administration of YGS placebo (90% starch and 10% YGS; 2.5 g thrice daily) or to a treatment group (TG, 19 patients) who received YGS for 4 weeks. The primary outcome measure was the change in Yale Global Tic Severity Scale (YGTSS) overall and subscale scores. RESULTS: The intensity score for phonic tics before oral administration of YGS, and after 2 weeks, 3 weeks and 4 weeks was not significantly different between CG and TG groups (2.94 ± 1.14 vs 2.79 ± 1.08, p = .686; 2.29 ± 1.21 vs 1.95 ± 1.08, p = .370; 2.41 ± 1.18 vs 2.05 ± 1.51, p = .435; and 2.29 ± 1.26 vs 1.84 ± 1.42, p = .323, respectively), while the intensity score for phonic tics after 1-week oral administration of YGS in the TG was 1.89 ± 1.10 lower than 3.06 ± 1.39 in the CG (p = .008). CONCLUSION: Oral administration of YGS for 1 week only reduced the intensity of phonic tics compared with oral administration of YGS placebo, suggesting that YGS can reduce their intensity for a short period, and the compliance of oral administration of YGS for 4 weeks can be accepted in children and adolescents with Tourette's Syndrome. However, because this study was preliminary, the selection of an appropriate placebo and dosage and long-term observations are crucial areas for future studies.
引用
- Huang CH, Liao WL, Lee DY, et al. Effects of Yi-Gan-san on the psychiatric behavior of children and adolescents with Tourette's Syndrome: A randomized, double-blind, controlled preliminary study. J Ethnopharmacol. 2022. PMID: 35182665. doi:10.1016/j.jep.2022.115098
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。